Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy

ACS Appl Mater Interfaces. 2024 Feb 14;16(6):6689-6708. doi: 10.1021/acsami.3c15686. Epub 2024 Feb 1.

Abstract

Tumor development and metastasis are closely related to the complexity of the metabolism network. Recently, metabolism reprogramming strategies have attracted much attention in tumor metabolism therapy. Although there is preliminary success of metabolism therapy agents, their therapeutic effects have been restricted by the effective reaching of the tumor sites of drugs. Nanodelivery systems with unique physical properties and elaborate designs can specifically deliver to the tumors. In this review, we first summarize the research progress of nanodelivery systems based on tumor metabolism reprogramming strategies to enhance therapies by depleting glucose, inhibiting glycolysis, depleting lactic acid, inhibiting lipid metabolism, depleting glutamine and glutathione, and disrupting metal metabolisms combined with other therapies, including chemotherapy, radiotherapy, photodynamic therapy, etc. We further discuss in detail the advantages of nanodelivery systems based on tumor metabolism reprogramming strategies for tumor therapy. As well as the opportunities and challenges for integrating nanodelivery systems into tumor metabolism therapy, we analyze the outlook for these emerging areas. This review is expected to improve our understanding of modulating tumor metabolisms for enhanced therapy.

Keywords: metabolism heterogeneity; metabolism reprogramming strategies; nanodelivery systems; tumor metabolism; tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Glycolysis
  • Humans
  • Lipid Metabolism
  • Metabolic Reprogramming*
  • Neoplasms* / drug therapy
  • Neoplasms* / pathology
  • Tumor Microenvironment